7:00 a.m. - 5:00 p.m. |
Registration |
7:00 a.m. - 8:00 a.m. |
Breakfast |
7:55 a.m. - 8:00 a.m. |
Welcome Address
Vickie Shannon, MD, MD Anderson Cancer Center, Houston [Pulmonologist] |
8:00 a.m. - 9:30 a.m. |
Complex Topics in Immunotherapy
Moderator: Vickie Shannon, MD, MD Anderson Cancer Center, Houston [Pulmonologist]
- Operating During and After Immunotherapy
- Jessica Donington, MD, MSCR, University of Chicago, Chicago [S]
- Combining IO and RT
- Salma Jabbour, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey [R]
- IO Rechallenge After Prior Immunotherapy or Immune Toxicity
- Christine Bestvina, MD, University of Chicago, Chicago [M]
- Patient Selection: Driver Mutations and Biomarker or Clinical Subsets
- Julia Rotow, MD, Dana-Farber Cancer Institute, Boston [M]
- Q&A
|
9:30 a.m. -10:00 a.m. |
Coffee Break and Research Feature in Exhibit Hall
|
10:00 a.m. - 10:45 a.m. |
Overcoming Obstacles in Oncology - Session 3: Frailty and Poor Performance Status Patients
Moderator: Carolyn Presley, MD, The Ohio State University, Columbus, Ohio [M]
Table Topics:
- The Role of Dementia
- Carolyn Presley, MD, The Ohio State University, Columbus, Ohio [M]
- Screening for Measurements of Fraility and Mitigation for Faility
- Mark K. Ferguson, MD, University of Chicago, Chicago [S]
Overcoming Obstacles in Oncology - Session 4: Optimizing Survivorship
Moderator: Ticiana Leal, MD, Winship Cancer Institute of Emory University [M]
Table Topics:
- Chronic Issues from Systemic Therapy
- Salma Jabbour, MD, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey [R]
- Financial Toxicity
- Fumiko Chino, MD, Memorial Sloan Kettering Cancer Center, New York [R]
- Smoking Cessation and Optimizing Pulmonary Function
- Vickie Shannon, MD, MD Anderson Cancer Center, Houston [Pulmonologist]
|
10:45 a.m. - 11:45 a.m. |
Challenging Cases in the Clinic
Moderator: Jeffrey Bradley, MD, FASTRO, Emory University School of Medicine, Atlanta [R]
Panelists:
- Megan Daly, MD, University of California, Davis, Sacramento, California [R]
- Mark K. Ferguson, MD, University of Chicago, Chicago [S]
- Ticiana Leal, MD, Winship Cancer Institute of Emory University [M]
- Vickie Shannon, MD, MD Anderson Cancer Center, Houston [Pulmonologist]
|
11:45 a.m. - 12:45 p.m. |
Lunch and Poster Viewing in the Exhibit Hall
Early-career and Trainee Networking Luncheon: Launching Your Successful Career
- How to Get Your Paper Published
- Sue Yom, MD, PhD, FASTRO, University of California, San Francisco
- Finding Personal/Professional Balance
- Kristin Higgins, MD, Winship Cancer Institute, Emory University, Atlanta
- Seeking Out and Maintaining Mentoring Relationships
- Percy Lee, MD, MD Anderson Cancer Center, Houston, Texas [R]
|
12:45 p.m. - 2:00 p.m. |
Oral Abstract Session
Moderator: David Carbone, MD, PhD, The Ohio State University, Columbus, Ohio [S]
- Comparison of National Comprehensive Cancer Network and American College of Surgeons Commission on Cancer Lymph Node Sampling Guidelines for Non-small Cell Lung Cancer
- Brendan Heiden, MD, MPHS, Washington University School of Medicine, St. Louis
- Impact of Mesothelioma Histologic Subtype and Use of Cancer-directed Surgery on Outcomes in the National Cancer Database
- Arian Mansur, BA, Massachusetts General Hospital, Boston
- Toxicity and Survival Outcomes from Intensity Modulated Proton Therapy-based Re-irradiation in Patients with Non-Small Cell Lung Cancer
- Pranshu Mohindra, MD, MBBS, University of Maryland School of Medicine, Baltimore
- Hot Spot Not Hot Enough? Differences in Local Control for Non-small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy Based on Maximum Point Dose within the Planning Target Volume
- Erica L. Braschi, BS, University of Florida College of
Medicine, Gainesville, Florida
- Prospective Evaluation of Limited Stage Small Cell Lung Cancer (LS-SCLC) Fractionation Regimen Usage and Toxicity in a Large Statewide Quality Collaborative
- Steven Allen, MD, PhD, University of Michigan, Ann Arbor, Michigan
- Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
- Mirek Fatyga, PhD, Mayo Clinic Arizona, Phoenix
- FLT-PET/CT in Non-small Cell Lung Cancer treated with SBRT- A Pilot Study
- Shirley Lewis, MD, DNB, FRCR, University of Toronto, Toronto, Canada
- Tepotinib in Patients with Advanced NSCLC with MET Amplification (METamp)
- Xiuning Le, MD, University of Texas, MD Anderson Cancer Center, Houston, Texas
|
2:15 p.m. - 2:45 p.m. |
Coffee Break and Research Feature in Exhibit Hall |
2:45 p.m. - 4:00 p.m. |
Hot Topic: Precision Diagnostics
Moderator: Kurt Schalper, MD, PhD, Yale School of Medicine, New Haven, Connecticut [Pathologist]
- Molecular Diagnostics: Who, Which, When, Why, and How
- Lynette Sholl, MD, Brigham and Women’s Hospital, Boston [Surgical Pathologist]
- Why to Wait for Molecular Results Before Initiating Therapy
- Shirish Gadgeel, MD, Henry Ford Health System, Detroit [M]
- Types of Liquid Biopsies and When to Use Them
- Maximilian Diehn, MD, PhD, Stanford University, Stanford, California [R]
- Future Directions in Molecular Diagnostics: IO Biomarkers, STK11
- Kurt Schalper, MD, PhD, Yale School of Medicine, New Haven, Connecticut [Pathologist]
- Q&A
|
4:00 p.m. - 5:00 p.m. |
Screening and Other Diagnostic Technologies
- Screening and How Imaging/Staging Availability Affects Survival
- Douglas Arenberg, MD, University of Michigan, Ann Arbor, Michigan [Pulmonologist]
- Diagnostics
- Claudia Henschke, MD, PhD, Mount Sinai Hospital, New York [Radiologist]
- Staging
- Brendon Stiles, MD, Montefiore-Einstein Cancer Center, New York [S]
- Q&A
|